A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
Objectives This study aims to assess travel time, associated costs, challenges and factors influencing healthcare facility choices among persons with cancer in Southern India. Design An explanatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback